Merck KGaA Stock – Fundamental Analysis

Price
141.90
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 3/10/2026)

Balance Sheet Total Assets 52,100,000,000.00 ROE 54.88 %
Balance Sheet Total Equity 28,592,000,000.00 ROA 5.01 %
Cashflow Capital Expenditures -1,584,000,000.00 P/FCF 26.28
Cashflow Free Cash Flow 2,348,000,000.00 – –
Cashflow Operating Cash Flow 3,932,000,000.00 P/CF 15.69
Income Earnings per Share (diluted) 6.00 Div. Yield –
Income Net Income 2,608,000,000.00 P/E 23.65
Income Shares Outstanding 434,778,000.00 P/B 2.16
Income Total Revenue 21,102,000,000.00 P/S 2.92

Ratios calculated on: 10/14/2026

Company Description

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Performance Materials and Merck Millipore business divisions form together the Chemicals business sector

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.merckgroup.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more